CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -50.0% | 3,180 | -28.9% | 0.00% | – |
| Q1 2022 | $14,000 | -22.2% | 4,474 | +7.1% | 0.00% | – |
| Q4 2021 | $18,000 | -47.1% | 4,179 | 0.0% | 0.00% | – |
| Q3 2021 | $34,000 | +3.0% | 4,179 | -4.0% | 0.00% | – |
| Q2 2021 | $33,000 | -19.5% | 4,355 | -6.9% | 0.00% | – |
| Q1 2021 | $41,000 | +5.1% | 4,677 | -4.3% | 0.00% | – |
| Q4 2020 | $39,000 | 0.0% | 4,886 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | -30.4% | 4,886 | -14.1% | 0.00% | – |
| Q2 2020 | $56,000 | +64.7% | 5,691 | +15.9% | 0.00% | – |
| Q1 2020 | $34,000 | +41.7% | 4,909 | -21.1% | 0.00% | – |
| Q4 2019 | $24,000 | -4.0% | 6,219 | +23.8% | 0.00% | – |
| Q3 2019 | $25,000 | -24.2% | 5,023 | 0.0% | 0.00% | – |
| Q2 2019 | $33,000 | -13.2% | 5,023 | 0.0% | 0.00% | – |
| Q1 2019 | $38,000 | -7.3% | 5,023 | 0.0% | 0.00% | – |
| Q4 2018 | $41,000 | -25.5% | 5,023 | +18.6% | 0.00% | – |
| Q3 2018 | $55,000 | +14.6% | 4,235 | 0.0% | 0.00% | – |
| Q2 2018 | $48,000 | – | 4,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |